-transparent.png){kind=logo}
Methylergometrine concentrations in the maternal plasma and breast milk were determined by a radioimmunoassay during continuous treatment with 0.125 mg of methylergometrine 3 times daily. On the fifth postpartum day at 8:00 a.m. the patients (n=8) took 2 tablets of Myomergin (0.250 mg of methylergometrine) orally, and the levels in the plasma and milk were determined at 1 and 8 hr after the drug administration. Measurable amounts of the drug were found only in 5 out of 16 milk samples. It was concluded that this oxytocic drug does not appear in the breast milk in quantities sufficient to affect the infant. No cumulation in the plasma or in the breast milk was found.
Related Publications
R Erkkola, and
J Kanto, and
H Allonen, and
T Kleimola, and
R Mäntylä
September 1981,
International journal of clinical pharmacology, therapy, and toxicology,
R Erkkola, and
J Kanto, and
H Allonen, and
T Kleimola, and
R Mäntylä
June 1978,
International journal of clinical pharmacology and biopharmacy,
R Erkkola, and
J Kanto, and
H Allonen, and
T Kleimola, and
R Mäntylä
January 1990,
Acta dermato-venereologica,
R Erkkola, and
J Kanto, and
H Allonen, and
T Kleimola, and
R Mäntylä
August 2018,
Journal of clinical psychopharmacology,
R Erkkola, and
J Kanto, and
H Allonen, and
T Kleimola, and
R Mäntylä
May 1984,
British journal of clinical pharmacology,
R Erkkola, and
J Kanto, and
H Allonen, and
T Kleimola, and
R Mäntylä
October 1984,
Journal of clinical pharmacology,
R Erkkola, and
J Kanto, and
H Allonen, and
T Kleimola, and
R Mäntylä
January 1986,
European journal of clinical pharmacology,
R Erkkola, and
J Kanto, and
H Allonen, and
T Kleimola, and
R Mäntylä
May 1992,
Antimicrobial agents and chemotherapy,
R Erkkola, and
J Kanto, and
H Allonen, and
T Kleimola, and
R Mäntylä
May 1977,
Acta pharmacologica et toxicologica,
R Erkkola, and
J Kanto, and
H Allonen, and
T Kleimola, and
R Mäntylä
September 1985,
Journal of clinical and hospital pharmacy,
